Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) FCF Margin (2019 - 2025)

Bioadaptives' FCF Margin history spans 7 years, with the latest figure at 3266.6% for Q3 2025.

  • For Q3 2025, FCF Margin changed N/A year-over-year to 3266.6%; the TTM value through Sep 2025 reached 5868.49%, down 465925.0%, while the annual FY2024 figure was 1969.51%, 118613.0% down from the prior year.
  • FCF Margin for Q3 2025 was 3266.6% at Bioadaptives, up from 3447.72% in the prior quarter.
  • Across five years, FCF Margin topped out at 343.35% in Q1 2024 and bottomed at 7623.11% in Q2 2024.
  • The 5-year median for FCF Margin is 1186.57% (2022), against an average of 1756.51%.
  • The largest annual shift saw FCF Margin tumbled -519186bps in 2024 before it skyrocketed 417539bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 919.32% in 2021, then rose by 25bps to 690.36% in 2022, then tumbled by -84bps to 1267.82% in 2023, then plummeted by -501bps to 7623.11% in 2024, then surged by 57bps to 3266.6% in 2025.
  • Per Business Quant, the three most recent readings for BDPT's FCF Margin are 3266.6% (Q3 2025), 3447.72% (Q2 2025), and 7623.11% (Q2 2024).